VVOS
Vivos Therapeutics Inc
NASDAQ: VVOS · HEALTHCARE · MEDICAL DEVICES
$0.80
+2.26% today
Updated 2026-04-30
Market cap
$11.46M
P/E ratio
—
P/S ratio
0.66x
EPS (TTM)
$-2.07
Dividend yield
—
52W range
$1 – $8
Volume
0.2M
Vivos Therapeutics Inc (VVOS) Financial statements
SEC filings — annual and quarterly data.
Cash flow — annual
| Item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Operating cash flow | $-5.31M | $-5.34M | $-5.68M | $-15.73M | $-19.59M | $-11.95M | $-12.69M | $-15.26M |
| Capital expenditures | $1.25M | $175599.00 | $120252.00 | $2.40M | $924000.00 | $803000.00 | $568000.00 | $2.34M |
| Depreciation | — | — | — | — | — | — | — | — |
| Stock-based comp | $1.28M | $1.99M | $2.17M | $2.66M | $2.40M | $924000.00 | $762000.00 | $661000.00 |
| Free cash flow | $-6.56M | $-5.52M | $-5.80M | $-18.13M | $-20.51M | $-12.75M | $-13.26M | $-17.60M |
| Investing cash flow | — | — | — | — | — | — | — | — |
| Financing cash flow | — | — | — | — | — | — | — | — |
| Dividends paid | — | $3.76M | $3.72M | — | — | — | — | — |
| Share repurchases | — | — | — | — | — | — | — | — |
| Debt repayment | — | — | — | — | — | — | — | — |
| Net change in cash | — | — | — | — | — | — | — | — |